Held by 2 specialist biotech funds
**Signal Note: Eventide/LBRT Position** This position appears to be a sector rotation signal rather than a biotech-specific development—Liberty Energy is an oilfield services company, not a healthcare name. Eventide's move likely reflects either portfolio rebalancing away from biotech valuations or a thematic pivot toward energy infrastructure; without disclosed rationale, the $36.4M position warrants monitoring as a potential indicator of conviction shifts within their values-based framework. No drug, indication, or clinical catalyst is applicable to this holding.